Browse Wiki & Semantic Web

Jump to: navigation, search
Http://dbpedia.org/resource/Lindy Durrant
  This page has no properties.
hide properties that link here 
  No properties link to this page.
 
http://dbpedia.org/resource/Lindy_Durrant
http://dbpedia.org/ontology/abstract Lindy Durrant is a British immunologist whLindy Durrant is a British immunologist who is Professor of Cancer Immunotherapy at the University of Nottingham and Chief Scientific Officer and Chief Executive Officer of the UK AIM listed biotech company Scancell Ltd. Durrant's work focusses on harnessing the immune system to treat cancer and infectious disease. Across her career Durrant has developed a panel of monoclonal antibodies which recognise tumour associated glycans, pioneered novel antibody engineering technology to enhance the avidity of monoclonal antibodies as well as developed a number of different cancer vaccine platforms to target cancers such as melanoma, triple negative breast cancer, head and neck cancer amongst others.ncer, head and neck cancer amongst others.
http://dbpedia.org/ontology/almaMater http://dbpedia.org/resource/University_of_Manchester + , http://dbpedia.org/resource/Paterson_Institute_for_Cancer_Research +
http://dbpedia.org/ontology/institution http://dbpedia.org/resource/University_of_Nottingham +
http://dbpedia.org/ontology/wikiPageID 70663403
http://dbpedia.org/ontology/wikiPageLength 9128
http://dbpedia.org/ontology/wikiPageRevisionID 1101533042
http://dbpedia.org/ontology/wikiPageWikiLink http://dbpedia.org/resource/Melanoma + , http://dbpedia.org/resource/CD4%2B_T_cells_and_antitumor_immunity + , http://dbpedia.org/resource/COVID-19_pandemic + , http://dbpedia.org/resource/DNA_vaccine + , http://dbpedia.org/resource/Triple-negative_breast_cancer + , http://dbpedia.org/resource/Fragment_crystallizable_region + , http://dbpedia.org/resource/Coronavirus_spike_protein + , http://dbpedia.org/resource/Coronavirus_nucleocapsid_protein + , http://dbpedia.org/resource/Monoclonal_antibody + , http://dbpedia.org/resource/COVID-19_vaccine + , http://dbpedia.org/resource/Post-translational_modification + , http://dbpedia.org/resource/Paterson_Institute_for_Cancer_Research + , http://dbpedia.org/resource/SCIB1 + , http://dbpedia.org/resource/Head_and_neck_cancer + , http://dbpedia.org/resource/Glycan + , http://dbpedia.org/resource/CD8 + , http://dbpedia.org/resource/Category:Alumni_of_the_University_of_Manchester + , http://dbpedia.org/resource/Neutralizing_antibody + , http://dbpedia.org/resource/Cytotoxicity + , http://dbpedia.org/resource/Category:Year_of_birth_missing_%28living_people%29 + , http://dbpedia.org/resource/Category:Living_people + , http://dbpedia.org/resource/University_of_Manchester + , http://dbpedia.org/resource/University_of_Nottingham + , http://dbpedia.org/resource/Category:Academics_of_the_University_of_Nottingham + , http://dbpedia.org/resource/T_cell + , http://dbpedia.org/resource/Nottingham_Trent_University +
http://dbpedia.org/property/almaMater http://dbpedia.org/resource/University_of_Manchester + , Paterson Institute for Cancer Research
http://dbpedia.org/property/name Lindy Durrant
http://dbpedia.org/property/wikiPageUsesTemplate http://dbpedia.org/resource/Template:Reflist + , http://dbpedia.org/resource/Template:Cite_Q + , http://dbpedia.org/resource/Template:Short_description + , http://dbpedia.org/resource/Template:Improve_categories + , http://dbpedia.org/resource/Template:Use_dmy_dates + , http://dbpedia.org/resource/Template:Infobox_scientist + , http://dbpedia.org/resource/Template:BLP_sources + , http://dbpedia.org/resource/Template:Authority_control +
http://dbpedia.org/property/workplaces http://dbpedia.org/resource/University_of_Nottingham + , Scancell Ltd
http://purl.org/dc/terms/subject http://dbpedia.org/resource/Category:Alumni_of_the_University_of_Manchester + , http://dbpedia.org/resource/Category:Year_of_birth_missing_%28living_people%29 + , http://dbpedia.org/resource/Category:Living_people + , http://dbpedia.org/resource/Category:Academics_of_the_University_of_Nottingham +
http://www.w3.org/ns/prov#wasDerivedFrom http://en.wikipedia.org/wiki/Lindy_Durrant?oldid=1101533042&ns=0 +
http://xmlns.com/foaf/0.1/isPrimaryTopicOf http://en.wikipedia.org/wiki/Lindy_Durrant +
http://xmlns.com/foaf/0.1/name Lindy Durrant
owl:sameAs http://dbpedia.org/resource/Lindy_Durrant + , http://www.wikidata.org/entity/Q111772322 + , https://global.dbpedia.org/id/GQbX4 +
rdf:type http://dbpedia.org/ontology/Animal + , http://www.wikidata.org/entity/Q215627 + , http://schema.org/Person + , http://dbpedia.org/ontology/Eukaryote + , http://dbpedia.org/ontology/Species + , http://dbpedia.org/ontology/Person + , http://www.wikidata.org/entity/Q729 + , http://xmlns.com/foaf/0.1/Person + , http://www.wikidata.org/entity/Q19088 + , http://dbpedia.org/ontology/Scientist + , http://www.wikidata.org/entity/Q5 + , http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#NaturalPerson + , http://www.wikidata.org/entity/Q901 +
rdfs:comment Lindy Durrant is a British immunologist whLindy Durrant is a British immunologist who is Professor of Cancer Immunotherapy at the University of Nottingham and Chief Scientific Officer and Chief Executive Officer of the UK AIM listed biotech company Scancell Ltd. Durrant's work focusses on harnessing the immune system to treat cancer and infectious disease. Across her career Durrant has developed a panel of monoclonal antibodies which recognise tumour associated glycans, pioneered novel antibody engineering technology to enhance the avidity of monoclonal antibodies as well as developed a number of different cancer vaccine platforms to target cancers such as melanoma, triple negative breast cancer, head and neck cancer amongst others.ncer, head and neck cancer amongst others.
rdfs:label Lindy Durrant
hide properties that link here 
http://en.wikipedia.org/wiki/Lindy_Durrant + http://xmlns.com/foaf/0.1/primaryTopic
 

 

Enter the name of the page to start semantic browsing from.